Alpha CognitionACOG +1.28%32 Forward PE Ratio is 18.42 as of Jul. 03, 2026. GuruFocus rates ACOG with a GF Score™ of 32/100. The stock has 3 warning signs investors should review. Among 355 Biotechnology companies, Alpha Cognition ranks better than 55.77% on this metric.
Alpha Cognition (NAS:ACOG) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Alpha Cognition Forward PE Ratio Related Terms
Alpha Cognition Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Alpha Cognition's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alpha Cognition Forward PE Ratio Chart
Alpha Cognition Annual Data
Trend
2024-12
Forward PE Ratio
256.50
Alpha Cognition Quarterly Data
2024-09
2024-12
2025-03
2025-06
2025-09
Forward PE Ratio
32.15
256.50
276.50
455.25
18.15
ACOG vs HURA, MENS, ENLV: Forward PE Ratio Comparison
For the Biotechnology subindustry, Alpha Cognition's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpha Cognition Forward PE Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alpha Cognition's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Alpha Cognition's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Alpha Cognition (ACOG) has a Forward PE Ratio of 18.42 as of Jul. 03, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Alpha Cognition and its competitors. According to the industry distribution chart, Alpha Cognition ranks #157 out of 355 companies in the Biotechnology industry, placing it in the top 44.2%.
Is Alpha Cognition's Forward PE Ratio too high?
Alpha Cognition's current Forward PE Ratio is 18.42. The Biotechnology industry median Forward PE Ratio is 22.47. Alpha Cognition's value of 18.42 is 18% below this industry median. Based on the distribution chart, Alpha Cognition ranks #157 out of 355 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Alpha Cognition has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Cognition's Forward PE Ratio compare to HURA and MENS?
According to the Biotechnology industry distribution chart, Alpha Cognition ranks #157 out of 355 companies for Forward PE Ratio. This puts Alpha Cognition in the upper half of its industry. The industry median Forward PE Ratio is 22.47. Alpha Cognition's value of 18.42 is 18% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Biotechnology company?
The median Forward PE Ratio among Biotechnology companies is 22.47, based on 355 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpha Cognition's current Forward PE Ratio of 18.42 is 18% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Alpha Cognition and its competitors. For the Biotechnology industry, the median Forward PE Ratio is 22.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpha Cognition's current Forward PE Ratio is 18.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Cognition stock overvalued right now?
Alpha Cognition (ACOG) has a current Forward PE Ratio of 18.42. The current Forward PE Ratio is 18.42 and 18% below the Biotechnology industry median of 22.47. Alpha Cognition's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Alpha Cognition (ACOG), the current Forward PE Ratio is 18.42 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
32GF Score
Get the complete analysis for ACOG
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACOG has been successfully added to your 